Marques-Vidal, Pedro https://orcid.org/0000-0002-4548-8500
Waeber, Gérard
Vollenweider, Peter
Guessous, Idris
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33CSCO-122661, 33CS30-139468 and 33CS30-148401)
Faculty of Biology and Medicine of Lausanne (no number)
GlaxoSmithKline (no grant number)
Article History
Received: 26 October 2016
Accepted: 8 January 2018
First Online: 12 January 2018
Ethics approval and consent to participate
: This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the Institutional Ethics Committee of the University of Lausanne. Written informed consent was obtained from all participants.
: Not applicable.
: PV and GW received funding from the Swiss National Science Foundation (Bern, Switzerland); GlaxoSmithKline (Philadelphia, PA, USA) and the Faculty of Biology and Medicine of Lausanne (Lausanne, Switzerland) to conduct the CoLaus study. PMV and IG indicate no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.